Sort
39,280 grants matching “leukemia”
Enhancement of methotrexate uptake in childhood ALL
$306,742John J McGuire · Roswell Park Cancer Institute Corp · R01 · FY2006 · CA
MOLECULAR ANALYSIS OF THE DEL(20Q) IN MYELOID LEUKEMIAS
$306,742University Of Chicago · R01 · FY2003 · CA
Declining DNA repair in Aging Hematopoietic Stem Cell
$306,719Stanton L Gerson · Case Western Reserve University · R01 · FY2007 · AG
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
$306,715Childrens Hospital Of Philadelphia · R01 · FY2005 · CA
NMR Studies of Retroviral Nucleic Acid Binding Proteins
$306,711Michael F. Summers · University Of Maryland Baltimore County · R01 · FY2008 · GM
Replicative senescence as a tumor suppressive mechanism
$306,706Sandy S Chang · Yale University · R01 · FY2013 · CA
Retroviral Immunotoxins for Leukemia
$306,697Daniel A Vallera · University Of Minnesota · R01 · FY2006 · CA
Transcriptional Regulation by the HTLV-1 Tax Protein
$306,675Colorado State University-Fort Collins · R01 · FY2005 · CA
Transcriptional Regulation by the HTLV-1 Tax Protein
$306,675Colorado State University-Fort Collins · R01 · FY2004 · CA
Studies of the structural rearrangements associated with the dynamic spliceosome
$306,645Melanie Diane Ohi · University Of Michigan At Ann Arbor · R01 · FY2018 · GM
Enhancing treatments for myeloid leukemia associated with Down syndrome
$306,623Jeffrey W Taub · Wayne State University · R01 · FY2024 · CA
Molecular Characterization and Risk Stratification of Acute Myeloid Leukemia
$306,586Clara D Bloomfield · Ohio State University · P50 · FY2011 · CA
EPS: A Novel Hematopoietic Transcription Factor
$306,562John D Crispino · University Of Chicago · R01 · FY2006 · DK
RBP2 regulation through differential recruitment to genomic loci
$306,522Elizaveta V Benevolenskaya · University Of Illinois At Chicago · R01 · FY2014 · CA
Developing allogeneic iNKT cell adoptive therapy to improve outcomes for HSCT indications
$306,500Olivier Le Tonqueze · Mink Therapeutics Inc · R41 · FY2025 · AI
Development and Application of Biomarkers of Exposure - Biomedical
$306,480Stephen M Rappaport · Univ Of North Carolina Chapel Hill · P42 · FY2006 · ES
BAALC in neurogenesis and hematopoiesis
$306,475Ohio State University · R01 · FY2004 · CA
BAALC in neurogenesis and hematopoiesis
$306,475Ohio State University · R01 · FY2005 · CA
Chronic Lymphocytic Leukemia:Epigenetic Targeted Therapy
$306,475Ohio State University · R21 · FY2004 · CA
Epigenetic Targeted Therapy for Chronic Lymphocytic Leu*
$306,475Ohio State University · R21 · FY2005 · CA
Translating CD33 genetic mechanism into a novel Alzheimers therapeutic
$306,475Steven Estus · University Of Kentucky · R01 · FY2014 · AG
Role of a pro-apoptotic Bcl-2 protein in the survival and death of leukemia cells
$306,473Ameeta Kelekar · University Of Minnesota · R01 · FY2013 · CA
Tissue Banking and Molecular Assessment
$306,470Jeffery Lorne Kutok · Dana-Farber Cancer Inst · P01 · FY2010 · CA
Context-specific Functions of CDK8
$306,430Jun-Yuan Ji · Texas A&M University Health Science Ctr · R01 · FY2015 · DK
Context-specific Functions of CDK8
$306,430Jun-Yuan Ji · Texas A&M University Health Science Ctr · R01 · FY2017 · DK